CRYOPDP in the news

Cryoport faces a critical earnings report to prove its financial stability and leadership in the specialized cold chain logistics market for cell and gene therapies.

DHL acquired CRYOPDP for $200 million to expand its temperature-controlled logistics capabilities for the life sciences industry.

Cryoport sold its CRYOPDP business to DHL Group for $200 million and launched a strategic partnership to expand life sciences logistics globally.

Cryoport divested CRYOPDP to DHL for $200 million and formed a strategic partnership with DHL to enhance life sciences logistics.

CryoPDP is being sold by its parent company Cryoport, transitioning the temperature-controlled logistics specialist back to European ownership.

DHL is acquiring Cryopdp for $195 million to strengthen its temperature-controlled healthcare logistics and high-value pharmaceutical delivery capabilities.

DHL Group acquired Cryopdp, a white-glove logistics specialist, to strengthen its position in the life sciences and healthcare logistics market.

DHL Group is acquiring CRYOPDP to expand its cold-chain logistics capabilities for clinical trials and specialized biopharmaceuticals.

DHL Group is acquiring temperature-controlled logistics specialist CryoPDP for $195 million to expand its high-margin pharmaceutical and life sciences delivery capabilities.

DHL Group acquired temperature-controlled logistics provider CRYOPDP from Cryoport to expand its specialized healthcare and clinical trial shipping capabilities.

DHL Group has acquired temperature-controlled logistics specialist CRYOPDP from Cryoport and entered a strategic supply chain partnership.

DHL Group acquired CRYOPDP from Cryoport to enhance its specialized pharma logistics and formed a strategic partnership with Cryoport for global life sciences and healthcare supply chain services.

DHL Group acquires CRYOPDP, a specialty courier for life sciences, and forms a strategic partnership with Cryoport to bolster healthcare supply chain services.

DHL is acquiring Cryopdp, a U.S. pharmaceutical logistics firm, to expand its presence in the pharma sector.

CRYOPDP, an Air Liquide subsidiary providing temperature-controlled logistics for healthcare with over 50M  turnover, is becoming autonomous with Hivest's support.

Specialized global logistics provider delivers high-precision temperature-controlled transport and lab relocation services for the healthcare and life sciences sectors.

Air Liquide finalized the divestment of its temperature-controlled logistics subsidiary CRYOPDP to Hivest Capital Partners.

Air Liquide has completed the sale of CRYOPDP to the private equity firm Hivest Capital Partners.